Role of Biliary Organoids in Cholestasis Research and Regenerative Medicine.

Semin Liver Dis

Section of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.

Published: May 2021

AI Article Synopsis

  • Translational studies in cholestatic diseases face challenges like rarity of disorders, difficulty in obtaining biliary tissue, and issues with culturing cholangiocytes.
  • Organoid technology offers a promising solution by allowing researchers to culture self-organizing cells from different sources, making personalized medicine more feasible.
  • This review covers current research on biliary organoids, their applications in regenerative medicine, and discusses challenges in standardizing the field.

Article Abstract

Translational studies in human cholestatic diseases have for years been hindered by various challenges, including the rarity of the disorders, the difficulty in obtaining biliary tissue from across the spectrum of the disease stage, and the difficulty culturing and maintaining primary cholangiocytes. Organoid technology is increasingly being viewed as a technological breakthrough in translational medicine as it allows the culture and biobanking of self-organizing cells from various sources that facilitate the study of pathophysiology and therapeutics, including from individual patients in a personalized approach. This review describes current research using biliary organoids for the study of human cholestatic diseases and the emerging applications of organoids to regenerative medicine directed at the biliary tree. Challenges and possible solutions to the current hurdles in this emerging field, particularly the need for standardization of terminology and clarity on source materials and techniques, are also discussed.

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0041-1728663DOI Listing

Publication Analysis

Top Keywords

biliary organoids
8
regenerative medicine
8
human cholestatic
8
cholestatic diseases
8
role biliary
4
organoids cholestasis
4
cholestasis regenerative
4
medicine translational
4
translational studies
4
studies human
4

Similar Publications

Standard: Human gastric cancer organoids.

Cell Regen

December 2024

Guangzhou National Laboratory, Guangzhou, 510005, China.

Gastric cancer is one of the most common malignancies with poor prognosis. The use of organoids to simulate gastric cancer has rapidly developed over the past several years. Patient-derived gastric cancer organoids serve as in vitro models that closely mimics donor characteristics, offering new opportunities for both basic and applied research.

View Article and Find Full Text PDF

Cholangiocyte organoids for disease, cancer, and regenerative medicine.

Eur J Cell Biol

December 2024

Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.

The biliary tract is a ductal network comprising the intrahepatic (IHBDs) and extrahepatic bile duct (EHBDs). Biliary duct disorders include cholangitis, neoplasms, and injury. However, the underlying mechanisms are not fully understood.

View Article and Find Full Text PDF

Understanding cell fate regulation in the liver is necessary to advance cell therapies for hepatic disease. Liver progenitor cells (LPC) contribute to tissue regeneration after severe hepatic injury yet signals instructing progenitor cell dynamics and fate are largely unknown. The Tissue Inhibitor of Metalloproteinases, TIMP1 and TIMP3 control the sheddases ADAM10 and ADAM17, key for NOTCH activation.

View Article and Find Full Text PDF

Drug-induced emesis is one of the major symptoms of gastrointestinal toxicity. Preclinical risk assessment of emesis has been challenging owing to the lack of suitable animal models or in vitro assay systems. One of the triggers of emesis is an excessive serotonin (5-HT) release from enterochromaffin (EC) cells in the intestinal tract, which activates the vomiting center in the brain stem and elicits the vomiting reflex.

View Article and Find Full Text PDF
Article Synopsis
  • The review investigates new regenerative medicine techniques to treat cholestatic liver fibrosis, which results from diseases like primary biliary cholangitis, leading to severe liver damage.
  • Understanding how these diseases progress is essential since current treatments mainly address underlying causes rather than the fibrosis itself.
  • The article highlights promising regenerative therapies like mesenchymal stem cell therapy and organoid technology, aiming to target fibrosis directly for better outcomes and potentially curative strategies.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!